These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 16917840

  • 1. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K, Takeshima T, Kashiwaya Y, Nakaso K, Nakashima K.
    J Neurosci Res; 2006 Nov 01; 84(6):1376-84. PubMed ID: 16917840
    [Abstract] [Full Text] [Related]

  • 2. Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity.
    de Oliveira DM, Barreto G, Galeano P, Romero JI, Holubiec MI, Badorrey MS, Capani F, Alvarez LD.
    Hum Exp Toxicol; 2011 Sep 01; 30(9):1382-91. PubMed ID: 21081703
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec 01; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 4. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.
    Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T.
    J Neurosci Res; 2003 Nov 15; 74(4):589-97. PubMed ID: 14598303
    [Abstract] [Full Text] [Related]

  • 5. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
    Xie HR, Hu LS, Li GY.
    Chin Med J (Engl); 2010 Apr 20; 123(8):1086-92. PubMed ID: 20497720
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells.
    Molina-Jiménez MF, Sánchez-Reus MI, Andres D, Cascales M, Benedi J.
    Brain Res; 2004 May 29; 1009(1-2):9-16. PubMed ID: 15120578
    [Abstract] [Full Text] [Related]

  • 7. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B, Verma R, Khanna P, Sharma SK.
    Brain Res; 2008 Mar 27; 1201():122-7. PubMed ID: 18308296
    [Abstract] [Full Text] [Related]

  • 8. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
    Schmidt WJ, Alam M.
    J Neural Transm Suppl; 2006 Mar 27; (70):273-6. PubMed ID: 17017541
    [Abstract] [Full Text] [Related]

  • 9. Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction in rotenone-induced PC12 cells.
    Liu YM, Jiang B, Bao YM, An LJ.
    Toxicol In Vitro; 2008 Mar 27; 22(2):430-7. PubMed ID: 18082360
    [Abstract] [Full Text] [Related]

  • 10. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.
    Neurochem Int; 2006 Jul 27; 49(1):28-40. PubMed ID: 16490285
    [Abstract] [Full Text] [Related]

  • 11. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
    Nakaso K, Ito S, Nakashima K.
    Neurosci Lett; 2008 Feb 20; 432(2):146-50. PubMed ID: 18201823
    [Abstract] [Full Text] [Related]

  • 12. SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone.
    Knaryan VH, Samantaray S, Park S, Azuma M, Inoue J, Banik NL.
    J Neurochem; 2014 Jul 20; 130(2):280-90. PubMed ID: 24341912
    [Abstract] [Full Text] [Related]

  • 13. Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells.
    Naoi M, Yi H, Maruyama W, Inaba K, Shamoto-Nagai M, Akao Y, Gerlach M, Riederer P.
    Neurosci Lett; 2009 Nov 13; 465(2):118-22. PubMed ID: 19737600
    [Abstract] [Full Text] [Related]

  • 14. [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone].
    Liu YY, Zhao HY, Zhao CL, Duan CL, Lu LL, Yang H.
    Sheng Li Xue Bao; 2006 Oct 25; 58(5):421-8. PubMed ID: 17041725
    [Abstract] [Full Text] [Related]

  • 15. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
    Tai KK, Truong DD.
    J Neurosci Res; 2002 Aug 15; 69(4):559-66. PubMed ID: 12210849
    [Abstract] [Full Text] [Related]

  • 16. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
    Watabe M, Nakaki T.
    J Pharmacol Exp Ther; 2004 Dec 15; 311(3):948-53. PubMed ID: 15280438
    [Abstract] [Full Text] [Related]

  • 17. Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease.
    Kim S, Park SE, Sapkota K, Kim MK, Kim SJ.
    J Pharm Pharmacol; 2011 Oct 15; 63(10):1358-67. PubMed ID: 21899552
    [Abstract] [Full Text] [Related]

  • 18. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
    Gu M, Iravani MM, Cooper JM, King D, Jenner P, Schapira AH.
    J Neurochem; 2004 Dec 15; 91(5):1075-81. PubMed ID: 15569251
    [Abstract] [Full Text] [Related]

  • 19. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.
    Sun H, He X, Liu C, Li L, Zhou R, Jin T, Yue S, Feng D, Gong J, Sun J, Ji J, Xiang L.
    ACS Chem Neurosci; 2017 Jan 18; 8(1):155-164. PubMed ID: 27731637
    [Abstract] [Full Text] [Related]

  • 20. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R, Nehru B.
    Neurochem Int; 2009 Nov 18; 55(6):369-75. PubMed ID: 19375462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.